5-fluorodopamine has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abu-Asab, M; Alesci, S; Brouwers, FM; Fojo, AT; Kiesewetter, DO; Kvetnansky, R; Martiniova, L; Marvelle, AF; Morris, JC; Pacak, K; Perera, SM; Reynolds, JC; Thomasson, D; Tischler, AS | 1 |
Chen, X; Cleary, S; Dawson, LF; Eisenhofer, G; Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Pacak, K; Phillips, JK; Powers, JF; Seidel, J; Thomasson, D | 1 |
2 other study(ies) available for 5-fluorodopamine and Liver Neoplasms
Article | Year |
---|---|
Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemotherapy, Adjuvant; Combined Modality Therapy; Dopamine; Female; Fluorine Radioisotopes; Histone Deacetylase Inhibitors; Iodine Radioisotopes; Liver Neoplasms; Mice; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Norepinephrine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Up-Regulation | 2011 |
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Neoplasms, Experimental; Norepinephrine Plasma Membrane Transport Proteins; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins | 2012 |